Related Experiment Video
Updated: Jul 2, 2025

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
Botulinum Toxin Injections to the Obliquus Capitis Inferioris Muscle for Dynamic Cervical Dystonia Improves
Robin Anne Bessemer1, Mandar Jog1
1Department of Clinical Neurological Sciences, London Health Sciences Centre, 339 Windermere Road, London, ON N6A 5A5, Canada.
Botulinum toxin injections into the obliquus capitis inferioris (OCI) muscle significantly improved quality of life for patients with cervical dystonia and head tremors. OCI injections are a promising early treatment option for this condition.
Area of Science:
- Neurology
- Movement Disorders
- Neurosurgery
Background:
- The obliquus capitis inferioris (OCI) muscle is implicated in cervical dystonia, causing torticaput movements and no-no head tremors.
- Limited data exist on the effectiveness of OCI injections for patient outcomes in cervical dystonia.
Purpose of the Study:
- To evaluate the impact of botulinum toxin injections into the OCI muscle on the subjective quality of life in patients experiencing dystonic head tremors.
Main Methods:
- Retrospective chart review of 25 patients with dystonic head tremors who received OCI injections.
- Data collected included Toronto Western Spasmodic Torticollis Scale-2 (TWSTRS-2) disability and pain subscales, TWSTRS-PSYCH scores, and global impression of severity.
Main Results:
- Significant improvements were observed in TWSTRS-2 disability (average change -2.8, p < 0.003) and pain (average change -4.6, p < 0.003) subscales.
- TWSTRS-PSYCH scores decreased from 5.6 to 3.7 (p < 0.004), and global impression of severity improved from 7.0 to 4.2 (p < 0.0003).
Conclusions:
- OCI botulinum toxin injections demonstrate significant improvements in patient-reported outcomes for cervical dystonia with head tremors.
- Consideration of OCI injections early in the treatment plan for cervical dystonia with no-no head tremors is recommended.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...

